Osteoporosis News

LAS VEGAS — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed patients who were prescribed anabolic bone-forming medications were not at increased risk for developing primary bone neoplasm.

Antiresorptive medications such as oral bisphosphonates have a minimal effect on change in lumbar spine trabecular bone score among older adults, according to a study published in The Journal of Bone and Mineral Research.

LAS VEGAS — Osteoporosis treatment started within 1 year of arthroplasty for a hip fracture was associated with a lower cumulative incidence of periprosthetic fractures vs. no osteoporosis treatment, presented data showed.

LAS VEGAS — Use of bisphosphonates prior to primary total hip arthroplasty may be an independent risk factor for periprosthetic fracture among patients with osteoporosis, according to results presented here.

Published results showed integration of fracture liaison and orthopedic services, as well as inpatient zoledronic acid administration, may improve osteoporosis pharmacotherapy rates among patients with fragility fractures.

Published results showed older patients who used a wheelchair may have a lower risk for most fractures compared with ambulatory controls.

Adults with type 2 diabetes who use statins have a lower risk for hip fracture than those who do not use statins, according to data published in Diabetes/Metabolism Research and Reviews.

Adults with obstructive sleep apnea demonstrated low predicted bone mineral density, which could impact the strength of their bones and teeth, according to study results published in Cranio.

Higher HDL levels may be associated with increased fracture risk for older adults independent of other risk factors, according to a post hoc analysis of the ASPREE study.

Women with osteoporosis receiving abaloparatide for 18 months followed by alendronate for 2 years had greater improvements in trabecular bone score than those receiving placebo, according to study findings.